NasdaqGS:TXGLife Sciences
Does Atera’s New Spatial Biology Platform Change The Bull Case For 10x Genomics (TXG)?
10x Genomics recently launched Atera, an in situ spatial biology platform for whole-transcriptome, single-cell–sensitivity analysis across fresh-frozen and FFPE tissues, unveiling early data and opening pre-orders at the AACR 2026 meeting.
Atera’s scale, early adoption by groups like Macrogen and the Human Cell Atlas, and integrated cloud analytics could materially expand 10x’s role in high-throughput spatial and AI-driven research workflows.
We’ll now examine how Atera’s...